If you are interested in learning more about the study, please send an email to mapt1d@vumc.org! Thank you!

  • Subjects between 8-35 years of age

  • Subjects with T1D must be imaged within 100 days of their date of diagnosis

  • Subjects must be able to read and provide assent/informed written consent

  • Subjects with pancreatitis, cystic fibrosis, pancreatic adenocarcinoma, or neuroendocrine tumors

  • Subjects who have any type of bioimplant activated by mechanical, electronic, or magnetic means because such devices may be displaced or malfunction

  • Subjects who have any type of ferromagnetic bioimplant that could potentially be displaced

  • Subjects who are pregnant or breast-feeding. Urine pregnancy test will be performed on women of child bearing potential who are not practicing appropriate contraception measures or menstruating.

  • Subjects who exhibit significant anxiety and/or claustrophobia

  • Subjects incapable of giving assent/informed written consent

  • For controls: subjects who have first degree relatives with T1D